All hail drug reps: Most cancer docs rely on pharma salespeople for info, survey finds

Here's a stat drugmakers would love to tout: With the cancer drug market exploding, oncologists rely on pharma's own sales reps for information. By a wide margin, in fact. Seventy-one percent of U.S. oncologists surveyed by Cardinal Health agreed sales reps play an important role in their education about new drugs—and, crucially, assistance in helping patients afford their meds.